CEBP:XETRA:XETRA-iShares VII PLC - iShares MSCI EMU USD Hedged ETF Acc (EUR)

ETF | Others |

Last Closing

USD 9.683

Change

-0.05 (-0.49)%

Market Cap

USD 0.20B

Volume

1.39K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-15 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.25 (-0.49%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.09 (-0.56%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.05 (-0.19%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.17 (-0.59%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.32 (-1.29%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.46 (-1.02%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

-2.74 (-1.91%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.33 (-0.64%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-1.35 (-1.31%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-8.90 (-1.49%)

USD 80.38B

ETFs Containing CEBP:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.50% 67% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.50% 66% D+ 66% D+
Trailing 12 Months  
Capital Gain 18.23% 64% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.23% 63% D 64% D
Trailing 5 Years  
Capital Gain 59.52% 79% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 59.52% 77% C+ 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 14.71% 84% B 82% B
Dividend Return 14.71% 84% B 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.17% 51% F 61% D-
Risk Adjusted Return 120.79% 100% F 99% N/A
Market Capitalization 0.20B 45% F 40% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.